Display Settings:

Format

Send to:

Choose Destination
    Lancet Oncol. 2005 Aug;6(8):599-607.

    Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.

    Source

    Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands.

    Abstract

    Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective therapeutic option. During the past 10 years, substantial new insights have been gained about molecular cell biology, molecular cytogenetics, and immunopathology, leading to better understanding of chondrosarcoma development at the molecular level, which will ultimately lead to better clinical understanding and possibly to the development of targeted treatment.

    PMID:
    16054571
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk